Reducing vascular disease risk in the type 2 diabetic patient.
Emory University School of Medicine, 1670 Clairmont Road, Atlanta, GA 30033, USA. editorjcl@yahoo.com
W Virgil
WV
Brown
Ronald B
RB
Goldberg
Maria
M
Lopes-Virella
Peter
P
Reaven
D000959:Antihypertensive Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000628:therapy*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000517:prevention & control; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D009765:Obesity / Q000150:complications
D000959:Antihypertensive Agents; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL